Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 20713986 
Zhao Q, et al. (2010) Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma. J Histochem Cytochem 58, 979-88 20713986
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Download Sites

S39-p - Fascin (human)
Orthologous residues
Fascin (human): S39‑p, Fascin (mouse): S39‑p, Fascin (rat): S39‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody
 Disease tissue studied:  esophageal cancer, esophageal carcinoma, cancer, squamous cell carcinoma
 Relevant cell lines - cell types - tissues:  EC109, EC171, EC8712, EC9706, esophagus, Kyse150 (esophageal), Kyse180 (esophageal), Kyse510 (esophageal), SHEEC
 Cellular systems studied:  cell lines, tissue
 Species studied:  human
Associated Diseases
Diseases: Alterations: Comments:
cancer, squamous cell carcinoma increased


Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.